Scientist in blue shirt thinking about research questions
               

 

What if I knew how well delivery of CRISPR/Cas9 ribonucleoproteins works?

 

Learn more about how delivery of CRISPR plasmids compares with delivery of ribonucleoproteins (RNPs) from our most recent white paper, Efficient CRISPR/Cas9 Delivery Using Nucleofector™ Technology: Comparison of Plasmid- and RNP-based Editing.

 

The authors developed a Nucleofection-based protocol for comparing NHEJ and HDR frequencies resulting from CRISPR/Cas9 delivered as plasmid or RNPs in K562 and Neuro2A cells.

 

 

Register to download the white paper

 


Genome Editing Publications List

 

Our up-to-date list of more than 90 selected publications provides a quick overview of published genome editing results using the non-viral Nucleofector™ Technology.

 

The list contains:

 

  • Editing tool: CRISPR, ZFN, TALENs or transposition systems
  • Author and Citation
  • Cell types
  • Substrate type: DNA, mRNA, or protein

Download the Publications List

 


 

Lonza also offers White Papers and Technical Guides on immunotherapy:

 

  • CRISPR/Cas9: using Nucleofection for efficient delivery of ribonucleoprotein (RNP) for targeted gene editing
  • Image-based 3D Natural Killer Cell-mediated Cytotoxicity Assay
  • Differentiation of peripheral blood CD4+ T cells into functional Th17 cells
  • Genome Editing using Nucleofector™ Technology

 

Register to Download

 

 

Find out more about Nucleofector™ Technology and genome editing


Find more information about immunotherapy on our website and in our eNewsletters, including the Immunotherapy and Hematopoietic Knowledge Centre and transfection technology.

 

Immunotherapy

Subscribe to eNews

 


 

To get in touch, please contact Scientific Support:


US:
Email scientific.support@lonza.com
Phone 800 521 0390


EU and International:
Email scientific.support.eu@lonza.com
Phone +49 221 99199 400